Position of chromatographic techniques in screening for detection of drugs or poisons in clinical and forensic toxicology and/or doping control

被引:135
作者
Maurer, HH [1 ]
机构
[1] Univ Saarland, Inst Expt & Clin Pharmacol & Toxicol, Dept Expt & Clin Toxicol, D-66421 Homburg, Saar, Germany
关键词
chromatography; diode-array detection; drugs; mass spectrometry; screening;
D O I
10.1515/CCLM.2004.250
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
This paper reviews chromatographic screening procedures for simultaneous detection of several drug classes relevant to clinical and forensic toxicology or doping control in urine or blood using gas chromatography-mass spectrometry (GC-MS), liquid chromatography coupled with a diode-array detector (LC-DAD) or a mass spectrometer (LC-MS). The pros and cons of the different techniques and procedures are discussed leading to the following conclusions and perspectives. GC-MS, especially in the electron ionization full-scan mode, is still the method of choice for comprehensive screening providing best separation power, specificity and universality, although requiring derivatization. LC-DAD is also often used for screening, but its separation power and its specificity are still inferior to those of GC-MS. Finally, LC-MS has shown to be an ideal supplement, especially for the detection of more polar, thermolabile and/or low-dose drugs, especially in blood plasma. It may become the gold standard in clinical and forensic toxicology and doping control if, at a later date, the costs of the apparatus will be markedly reduced, the current disadvantages like irreproducibility of fragmentation, reduction of ionization by matrix, etc. will be overcome, and finally if one of the increasing number of quite different techniques will become the apparatus standard.
引用
收藏
页码:1310 / 1324
页数:15
相关论文
共 153 条
[1]   Detection of beta-blockers in human urine by GC-MS-MS-EI:: perspectives for the antidoping control [J].
Amendola, L ;
Molaioni, F ;
Botrè, F .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2000, 23 (01) :211-221
[2]   Ion suppression in mass spectrometry [J].
Annesley, TM .
CLINICAL CHEMISTRY, 2003, 49 (07) :1041-1044
[3]   Fatal brain oedema after ingestion of ecstasy and benzylpiperazine [J].
Balmelli, C ;
Kupferschmidt, H ;
Rentsch, K ;
Schneemann, M .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2001, 126 (28-29) :809-811
[4]   Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors [J].
Baumann, P .
CLINICAL PHARMACOKINETICS, 1996, 31 (06) :444-469
[5]   Screening for detection of new antidepressants, neuroleptics, hypnotics, and their metabolites in urine by GC-MS developed using rat liver microsomes [J].
Bickeboeller-Friedrich, J ;
Maurer, HH .
THERAPEUTIC DRUG MONITORING, 2001, 23 (01) :61-70
[6]   Liquid chromatography-mass spectrometry as a routine method in forensic sciences: a proof of maturity [J].
Bogusz, MJ .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2000, 748 (01) :3-19
[7]   Applicability of various brands of mixed-phase extraction columns for opiate extraction from blood and serum [J].
Bogusz, MJ ;
Maier, RD ;
SchiwyBochat, KH ;
Kohls, U .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1996, 683 (02) :177-188
[8]  
Broussard LA, 2001, CLIN CHEM, V47, P127
[9]  
BRYANT SG, 1983, CLIN PHARMACY, V2, P525
[10]   Application of solvent microextraction to the analysis of amphetamines and phencyclidine in urine [J].
Casari, C ;
Andrews, ARJ .
FORENSIC SCIENCE INTERNATIONAL, 2001, 120 (03) :165-171